中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Enjaymo
    Enjaymo
    departments：血液科
    drug：注射剂
    Active：sutimlimab-jome
    indication：ENJAYMO是一种经典的补体抑制剂，可减少对补体的需求 用于成人感冒患者因溶血而输注红细胞凝集素病
    Licensor：Bioverativ USA Inc.
    Approved Country/Region：FDA
    Approval time：2022-02-04